Latest Octagon Capital Advisors LP Stock Portfolio
$834Million
Equity Portfolio Value
Last Reported on: 15 May, 2024
About Octagon Capital Advisors LP and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Octagon Capital Advisors LP reported an equity portfolio of $834.4 Millions as of 31 Mar, 2024.
The top stock holdings of Octagon Capital Advisors LP are APLS, ALPN, . The fund has invested 19.8% of it's portfolio in APELLIS PHARMACEUTICALS INC and 5.9% of portfolio in ALPINE IMMUNE SCIENCES INC.
The fund managers got completely rid off CYMABAY THERAPEUTICS INC (CBAY), ARCUS BIOSCIENCES INC (RCUS) and CELLDEX THERAPEUTICS INC NEW (CLDX) stocks. They significantly reduced their stock positions in INSMED INC (INSM) and BRIDGEBIO PHARMA INC (BBIO). Octagon Capital Advisors LP opened new stock positions in ARRIVENT BIOPHARMA INC, EYEPOINT PHARMACEUTICALS INC (EYPT) and OCULAR THERAPEUTIX INC (OCUL). The fund showed a lot of confidence in some stocks as they added substantially to PHATHOM PHARMACEUTICALS INC (PHAT), DIANTHUS THERAPEUTICS INC and CYTOKINETICS INC (CYTK).
The top stock holdings of Octagon Capital Advisors LP are APLS, ALPN, . The fund has invested 19.8% of it's portfolio in APELLIS PHARMACEUTICALS INC and 5.9% of portfolio in ALPINE IMMUNE SCIENCES INC.
The fund managers got completely rid off CYMABAY THERAPEUTICS INC (CBAY), ARCUS BIOSCIENCES INC (RCUS) and CELLDEX THERAPEUTICS INC NEW (CLDX) stocks. They significantly reduced their stock positions in INSMED INC (INSM) and BRIDGEBIO PHARMA INC (BBIO). Octagon Capital Advisors LP opened new stock positions in ARRIVENT BIOPHARMA INC, EYEPOINT PHARMACEUTICALS INC (EYPT) and OCULAR THERAPEUTIX INC (OCUL). The fund showed a lot of confidence in some stocks as they added substantially to PHATHOM PHARMACEUTICALS INC (PHAT), DIANTHUS THERAPEUTICS INC and CYTOKINETICS INC (CYTK).
New Buys
| Ticker | $ Bought |
|---|---|
| ARRIVENT BIOPHARMA INC | 34,716,900 |
| EYEPOINT PHARMACEUTICALS INC | 22,602,700 |
| OCULAR THERAPEUTIX INC | 22,067,500 |
| MIND MEDICINE MINDMED INC | 20,238,200 |
| PERSPECTIVE THERAPEUTICS INC | 17,514,900 |
| CORBUS PHARMACEUTICALS HLDGS | 15,892,200 |
| PRAXIS PRECISION MEDICINES I | 15,865,200 |
| TENAYA THERAPEUTICS INC | 14,926,400 |
New stocks bought by Octagon Capital Advisors LP
Additions
| Ticker | % Inc. |
|---|---|
| PHATHOM PHARMACEUTICALS INC | 810 |
| DIANTHUS THERAPEUTICS INC | 149 |
| CYTOKINETICS INC | 67.24 |
| AN2 THERAPEUTICS INC | 65.97 |
| DYNE THERAPEUTICS INC | 56.75 |
| ANAPTYSBIO INC | 37.5 |
| NUVATION BIO INC | 37.49 |
| STRUCTURE THERAPEUTICS INC | 22.37 |
Additions to existing portfolio by Octagon Capital Advisors LP
Reductions
| Ticker | % Reduced |
|---|---|
| INSMED INC | -11.21 |
| BRIDGEBIO PHARMA INC | -2.38 |
Octagon Capital Advisors LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| CYMABAY THERAPEUTICS INC | -63,154,000 |
| ROIVANT SCIENCES LTD | -28,007,600 |
| ARCUS BIOSCIENCES INC | -35,678,800 |
| XILIO THERAPEUTICS INC | -981,750 |
| CELLDEX THERAPEUTICS INC NEW | -28,060,500 |
| GRACELL BIOTECHNOLOGIES INC | -5,989,970 |
| JASPER THERAPEUTICS INC | -3,525,340 |
| INOZYME PHARMA INC | -1,704,000 |
Octagon Capital Advisors LP got rid off the above stocks
Current Stock Holdings of Octagon Capital Advisors LP
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| ACET | ADICET BIO INC | 0.22 | 767,799 | 1,804,330 | NEW | ||
| ACRS | ACLARIS THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| AKRO | AKERO THERAPEUTICS INC | 1.03 | 340,000 | 8,588,400 | NEW | ||
| ALLO | ALLOGENE THERAPEUTICS INC | 0.39 | 720,000 | 3,218,400 | NEW | ||
| ALPN | ALPINE IMMUNE SCIENCES INC | 5.90 | 1,241,300 | 49,205,100 | UNCHANGED | 0.00 | |
| ALVR | ALLOVIR INC | 0.38 | 4,200,000 | 3,170,580 | NEW | ||
| ANAB | ANAPTYSBIO INC | 0.44 | 165,000 | 3,715,800 | ADDED | 37.5 | |
| ANNX | ANNEXON INC | 1.76 | 2,050,000 | 14,698,500 | UNCHANGED | 0.00 | |
| ANTX | AN2 THERAPEUTICS INC | 0.43 | 1,103,000 | 3,584,750 | ADDED | 65.97 | |
| APLS | APELLIS PHARMACEUTICALS INC | 19.77 | 2,806,980 | 164,994,000 | UNCHANGED | 0.00 | |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 0.86 | 250,000 | 7,150,000 | NEW | ||
| AUTL | AUTOLUS THERAPEUTICS PLC | 0.14 | 176,000 | 1,122,880 | NEW | ||
| AVTE | AEROVATE THERAPEUTICS INC | 1.43 | 403,685 | 11,937,000 | UNCHANGED | 0.00 | |
| BBIO | BRIDGEBIO PHARMA INC | 2.56 | 690,000 | 21,334,800 | REDUCED | -2.38 | |
| CABA | CABALETTA BIO INC | 0.11 | 52,000 | 887,120 | NEW | ||
| CBAY | CYMABAY THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 2.79 | 2,060,100 | 23,279,100 | UNCHANGED | 0.00 | |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 1.91 | 405,000 | 15,892,200 | NEW | ||
| CYBN | CYBIN INC | 0.92 | 18,604,600 | 7,693,020 | NEW | ||
| CYTK | CYTOKINETICS INC | 1.63 | 194,000 | 13,601,300 | ADDED | 67.24 | |
| DYN | DYNE THERAPEUTICS INC | 4.23 | 1,242,940 | 35,287,200 | ADDED | 56.75 | |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 2.71 | 1,093,500 | 22,602,700 | NEW | ||
| FATE | FATE THERAPEUTICS INC | 0.46 | 520,800 | 3,822,670 | NEW | ||
| GLYC | GLYCOMIMETICS INC | 1.08 | 3,000,000 | 9,000,000 | UNCHANGED | 0.00 | |
| GOSS | GOSSAMER BIO INC | 1.30 | 9,187,880 | 10,841,700 | UNCHANGED | 0.00 | |
| GRCL | GRACELL BIOTECHNOLOGIES INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| IMVT | IMMUNOVANT INC | 1.06 | 273,289 | 8,829,970 | UNCHANGED | 0.00 | |
| INSM | INSMED INC | 3.71 | 1,140,000 | 30,928,200 | REDUCED | -11.21 | |
| INZY | INOZYME PHARMA INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| IPSC | CENTURY THERAPEUTICS INC | 0.27 | 540,000 | 2,257,200 | NEW | ||
| JSPR | JASPER THERAPEUTICS INC | 1.76 | 500,811 | 14,703,800 | NEW | ||
| JSPR | JASPER THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| LIFE | ATYR PHARMA INC | 0.16 | 700,000 | 1,365,000 | NEW | ||
| MIRM | MIRUM PHARMACEUTICALS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| MNMD | MIND MEDICINE MINDMED INC | 2.43 | 2,153,000 | 20,238,200 | NEW | ||
| MRSN | MERSANA THERAPEUTICS INC | 0.54 | 1,000,000 | 4,480,000 | NEW | ||
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 1.16 | 408,000 | 9,649,200 | NEW | ||
| NKTX | NKARTA INC | 0.31 | 240,000 | 2,594,400 | NEW | ||
| NUVB | NUVATION BIO INC | 0.60 | 1,374,870 | 5,004,530 | ADDED | 37.49 | |
| OCUL | OCULAR THERAPEUTIX INC | 2.64 | 2,425,000 | 22,067,500 | NEW | ||
| PEPG | PEPGEN INC | 0.66 | 376,117 | 5,528,920 | NEW | ||
| PHAT | PHATHOM PHARMACEUTICALS INC | 0.58 | 455,000 | 4,832,100 | ADDED | 810 | |
| PRAX | PRAXIS PRECISION MEDICINES I | 1.90 | 260,000 | 15,865,200 | NEW | ||
| PSTX | POSEIDA THERAPEUTICS INC | 0.28 | 736,000 | 2,347,840 | NEW | ||
| RAPT | RAPT THERAPEUTICS INC | 0.31 | 292,000 | 2,622,160 | UNCHANGED | 0.00 | |
| RCUS | ARCUS BIOSCIENCES INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ROIV | ROIVANT SCIENCES LTD | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| RPHM | RENEO PHARMACEUTICALS INC | 0.45 | 2,250,000 | 3,735,000 | UNCHANGED | 0.00 | |
| SANA | SANA BIOTECHNOLOGY INC | 0.43 | 360,800 | 3,608,000 | NEW | ||
| SLN | SILENCE THERAPEUTICS PLC | 0.81 | 315,000 | 6,804,000 | NEW | ||
| TERN | TERNS PHARMACEUTICALS INC | 0.49 | 625,000 | 4,100,000 | NEW | ||
| TNYA | TENAYA THERAPEUTICS INC | 1.79 | 2,854,000 | 14,926,400 | NEW | ||
| TSHA | TAYSHA GENE THERAPIES INC | 1.04 | 3,030,000 | 8,696,100 | NEW | ||
| VERU | VERU INC | 0.32 | 3,800,000 | 2,660,380 | UNCHANGED | 0.00 | |
| VINC | VINCERX PHARMA INC | 0.61 | 1,000,000 | 5,060,000 | NEW | ||
| VRDN | VIRIDIAN THERAPEUTICS INC | 1.30 | 620,000 | 10,856,200 | UNCHANGED | 0.00 | |
| VRNA | VERONA PHARMA PLC | 4.57 | 2,369,000 | 38,117,200 | UNCHANGED | 0.00 | |
| VTYX | VENTYX BIOSCIENCES INC | 0.99 | 1,501,110 | 8,256,130 | NEW | ||
| XLO | XILIO THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| DIANTHUS THERAPEUTICS INC | 4.96 | 1,380,670 | 41,420,000 | ADDED | 149 | ||
| ARRIVENT BIOPHARMA INC | 4.16 | 1,943,840 | 34,716,900 | NEW | |||
| STRUCTURE THERAPEUTICS INC | 2.60 | 506,604 | 21,713,000 | ADDED | 22.37 | ||
| PERSPECTIVE THERAPEUTICS INC | 2.10 | 14,718,400 | 17,514,900 | NEW | |||
| MINERALYS THERAPEUTICS INC | 0.85 | 550,000 | 7,100,500 | NEW | |||
| HELIX ACQUISITION CORP II | 0.31 | 250,000 | 2,587,500 | NEW |